Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Immunic, Inc. (IMUX) had Operating Cash Flow per Share of $-0.34 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-25.58M |
|
-- |
|
-- |
|
$25.99M |
|
$-25.99M |
|
$0.41M |
|
$-25.58M |
|
$-25.58M |
|
$-25.58M |
|
$-25.58M |
|
$-25.58M |
|
$-25.58M |
|
$-25.99M |
|
$-25.95M |
|
193.90M |
|
193.90M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$39.27M |
|
$0.64M |
|
$1.43M |
|
$40.70M |
|
$30.08M |
|
-- |
|
$0.13M |
|
$30.20M |
|
$10.50M |
|
$10.50M |
|
$10.50M |
|
98.65M |
|
| Cash Flow Statement Financials | |
$-66.53M |
|
$-0.15M |
|
$65.52M |
|
$35.67M |
|
$35.13M |
|
$-0.54M |
|
$7.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-66.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-243.63% |
|
-243.63% |
|
-62.84% |
|
-243.63% |
|
$0.11 |
|
$-0.34 |
|
|
Operating Cash Flow per Share |
$-0.34 |